TWO · Healthcare

Great Novel Therapeutics Biotech & Medicals (7427)

Biotechnology

Great Novel Therapeutics Biotech & Medicals (7427) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 7427

P/E ratio

18.00

Great Novel Therapeutics Biotech & Medicals (7427) — FAQ

What is 7427's P/E ratio?

The price-to-earnings (P/E) ratio for Great Novel Therapeutics Biotech & Medicals (7427) is 18.00 (data as of 2026-03-23).

Does Great Novel Therapeutics Biotech & Medicals pay a dividend?

Dividend yield is not available in the current snapshot for Great Novel Therapeutics Biotech & Medicals (7427). Check the MyAverix Finance app for the latest dividend data.

What sector is Great Novel Therapeutics Biotech & Medicals in?

Great Novel Therapeutics Biotech & Medicals (7427) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 7427 listed on?

7427 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)